Monocyte chemoattractant protein‑1 promotes the proliferation, migration and differentiation potential of fibroblast‑like synoviocytes via the PI3K/P38 cellular signaling pathway

Tong,Xiang; Zeng,Huangjian; Gu,Pengchen; Wang,Kai; Zhang,Han; Lin,Xiangjin

doi:10.3892/mmr.2020.10969

Monocyte chemoattractant protein‑1 promotes the proliferation, migration and differentiation potential of fibroblast‑like synoviocytes via the PI3K/P38 cellular signaling pathway

Authors:
- Xiang Tong
- Huangjian Zeng
- Pengchen Gu
- Kai Wang
- Han Zhang
- Xiangjin Lin
View Affiliations

Affiliations: Department of Orthopedic Surgery, The First Affiliated Hospital, College of Medicine, Zhejiang University, Hangzhou, Zhejiang 310003, P.R. China, Department of Pathology, The First Affiliated Hospital, College of Medicine, Zhejiang University, Hangzhou, Zhejiang 310003, P.R. China
Published online on: January 29, 2020 https://doi.org/10.3892/mmr.2020.10969
Pages: 1623-1632

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Rheumatoid arthritis (RA) is an autoimmune disease characterized by chronic inflammation of the joints and joint destruction. Monocyte chemoattractant protein 1 (MCP‑1) is highly expressed in the joints of patients suffering from RA. The present study aimed to evaluate the effects of MCP‑1 on the phenotype of fibroblast‑like synoviocytes (FLSs) and their differentiation potential towards vascular endothelial cells. The expression of MCP‑1 in collagen‑induced arthritis (CIA) rats was investigated by PCR, ELISA and immunohistology. Cell proliferation induced by MCP‑1 was measured using a Cell Counting Kit‑8 (CCK‑8) and 5‑Bromo‑2‑deoxyuridine ELISA assay. In addition, the effects of MCP‑1 on the migration of FLSs was examined using a Transwell assay. Activation of PI3K and P38 were investigated by western blotting following MCP‑1 treatment. The vascular endothelial cell markers, tumor necrosis factor α (TNF‑α) and interleukin‑1 β (IL‑β), were also examined by western blotting. LY294002 [PI3K inhibitor, (LY)] and SB203580 [P38 inhibitor, (SB)] were used to examine the proliferative and pro‑differentiation effect of PI3K and P38. The present findings showed that the expression level of MCP‑1 in the synovium of CIA rats was significantly higher compared with controls. The present in vitro study suggested that MCP‑1 increased the FLSs cell numbers with a maximal effect at 200 ng/ml, and induced the maximal phosphorylation of PI3K at 15 min and P38 at 30 min. In addition, MCP‑1 stimulation significantly increased the migration of FLSs. Furthermore, MCP‑1‑induced the expression of vascular endothelial growth factor and CD31 in FLSs. Suppression of PI3K and P38 was found to reduce MCP‑1 induced FLSs proliferation and migration, and decreased the expression levels of angiogenesis markers increased following MCP‑1 treatment. MCP‑1 was also found to increase the expression levels of both TNF‑α and IL‑β. Therefore, MCP‑1 could promote the proliferation and migration of FLSs, and was found to increase the expression levels of various angiogenesis markers via PI3K/P38, suggesting a role for this pathway in synovium hyperplasia in RA.

View Figures

View References

1	Aletaha D, Funovits J and Smolen JS: Physical disability in rheumatoid arthritis is associated with cartilage damage rather than bone destruction. Ann Rheum Dis. 70:733–739. 2011. View Article : Google Scholar : PubMed/NCBI
2	Feng Z, Zeng S, Wang Y, Zheng Z and Chen Z: Bisphosphonates for the prevention and treatment of osteoporosis in patients with rheumatic diseases: A systematic review and meta-analysis. PLoS One. 8:57. 2013. View Article : Google Scholar
3	Scott DL, Smith C and Kingsley G: Joint damage and disability in rheumatoid arthritis: An updated systematic review. Clin Exp Rheumatol. 21((5 Suppl 31)): S20–S27. 2003.PubMed/NCBI
4	Feng ZY, He ZN, Zhang B, Li YQ, Guo J, Xu YL, Han MY and Chen Z: Adenovirus-mediated osteoprotegerin ameliorates cartilage destruction by inhibiting proteoglycan loss and chondrocyte apoptosis in rats with collagen-induced arthritis. Cell Tissue Res. 362:187–199. 2015. View Article : Google Scholar : PubMed/NCBI
5	Sharif K, Jumah F, Oskouian R and Tubbs RS: Rheumatoid arthritis in review: Clinical, anatomical, cellular and molecular points of view. Clin Anat. 31:216–223. 2018. View Article : Google Scholar : PubMed/NCBI
6	Bustamante MF, Garcia-Carbonell R, Whisenant KD and Guma M: Fibroblast-like synoviocyte metabolism in the pathogenesis of rheumatoid arthritis. Arthritis Res Ther. 19:1102017. View Article : Google Scholar : PubMed/NCBI
7	Noss EH and Brenner MB: The role and therapeutic implications of fibroblast-like synoviocytes in inflammation and cartilage erosion in rheumatoid arthritis. Immunol Rev. 223:252–270. 2008. View Article : Google Scholar : PubMed/NCBI
8	Guo J, Zhao W, Cao X, Yang H, Ding J, Ding J, Tan Z, Ma X, Hao C, Wu L, et al: SIRT1 promotes tumor-like invasion of fibroblast-like synoviocytes in rheumatoid arthritis via targeting TIMP1. Oncotarget. 8:88965–88973. 2017. View Article : Google Scholar : PubMed/NCBI
9	Wang H, Chen W, Wang L, Li F, Zhang C and Xu L: Tumor necrosis factor receptor-associated factor 6 promotes migration of rheumatoid arthritis fibroblast-like synoviocytes. Mol Med Rep. 11:2761–2766. 2015. View Article : Google Scholar : PubMed/NCBI
10	Shi Y, Wu Q, Xuan W, Feng X, Wang F, Tsao BP, Zhang M and Tan W: Transcription factor SOX5 promotes the migration and invasion of fibroblast-like synoviocytes in part by regulating MMP-9 expression in collagen-induced arthritis. Front Immunol. 9:7492018. View Article : Google Scholar : PubMed/NCBI
11	Lochhead RB, Ordonez D, Arvikar SL, Aversa JM, Oh LS, Heyworth B, Sadreyev R, Steere AC and Strle K: Interferon-gamma production in Lyme arthritis synovial tissue promotes differentiation of fibroblast-like synoviocytes into immune effector cells. Cell Microbiol. 21:e129922019.PubMed/NCBI
12	Liou LB, Tsai WP, Chang CJ, Chao WJ and Chen MH: Blood monocyte chemotactic protein-1 (MCP-1) and adapted disease activity Score28-MCP-1: Favorable indicators for rheumatoid arthritis activity. PLoS One. 8:e553462013. View Article : Google Scholar : PubMed/NCBI
13	Zheng Y, Sun L, Jiang T, Zhang D, He D and Nie H: TNFα promotes Th17 cell differentiation through IL-6 and IL-1β produced by monocytes in rheumatoid arthritis. J Immunol Res. 2014:3853522014. View Article : Google Scholar : PubMed/NCBI
14	Darrieutort-Laffite C, Boutet MA, Chatelais M, Brion R, Blanchard F, Heymann D and Le Goff B: IL-1β and TNFα promote monocyte viability through the induction of GM-CSF expression by rheumatoid arthritis synovial fibroblasts. Mediators Inflamm. 2014:2418402014. View Article : Google Scholar : PubMed/NCBI
15	Zucali JR, Dinarello CA, Oblon DJ, Gross MA, Anderson L and Weiner RS: Interleukin 1 stimulates fibroblasts to produce granulocyte-macrophage colony-stimulating activity and prostaglandin E2. J Clin Invest. 77:1857–1863. 1986. View Article : Google Scholar : PubMed/NCBI
16	Satish LD, Sergey K, Shohreh A and Bassel ES: Monocyte chemoattractant protein-1 (MCP-1): An overview. J Interferon Cytokine Res. 29:313–326. 2009. View Article : Google Scholar : PubMed/NCBI
17	Rantapää-Dahlqvist S, Boman K, Tarkowski A and Hallmans G: Up regulation of monocyte chemoattractant protein-1 expression in anti-citrulline antibody and immunoglobulin M rheumatoid factor positive subjects precedes onset of inflammatory response and development of overt rheumatoid arthritis. Ann Rheum Dis. 66:121–123. 2007. View Article : Google Scholar : PubMed/NCBI
18	Ogata H, Takeya M, Yoshimura T, Takagi K and Takahashi K: The role of monocyte chemoattractant protein-1 (MCP-1) in the pathogenesis of collagen-induced arthritis in rats. J Pathol. 182:106–114. 2015. View Article : Google Scholar
19	Shiva S, Proudfoot AE, Park CC, Volin MV, Haines GK, Woods JM, Aikens CH, Handel TM and Pope RM: Inhibition of monocyte chemoattractant protein-1 ameliorates rat adjuvant-induced arthritis. J Immunol. 180:3447–3456. 2008. View Article : Google Scholar : PubMed/NCBI
20	Kuper C, Beck FX and Neuhofer W: Autocrine MCP-1/CCR2 signaling stimulates proliferation and migration of renal carcinoma cells. Oncol Lett. 12:2201–2209. 2016. View Article : Google Scholar : PubMed/NCBI
21	Salcedo R, Ponce ML, Young HA, Wasserman K, Ward JM, Kleinman HK, Oppenheim JJ and Murphy WJ: Human endothelial cells express CCR2 and respond to MCP-1: Direct role of MCP-1 in angiogenesis and tumor progression. Blood. 96:34–40. 2000. View Article : Google Scholar : PubMed/NCBI
22	Zhu Z, Huang P, Chong Y, George SK, Wen B, Han N, Liu Z, Kang L and Lin N: Nucleus pulposus cells derived IGF-1 and MCP-1 enhance osteoclastogenesis and vertebrae disruption in lumbar disc herniation. Int J Clin Exp Pathol. 7:8520–8531. 2014.PubMed/NCBI
23	Chen X, Wang Y, Nelson D, Tian S, Mulvey E, Patel B, Conti I, Jaen J and Rollins BJ: CCL2/CCR2 regulates the tumor microenvironment in HER-2/neu-driven mammary carcinomas in mice. PLoS One. 11:e01655952016. View Article : Google Scholar : PubMed/NCBI
24	Du J, Zhang F and Guo J: miR137 decreases proliferation, migration and invasion in rheumatoid arthritis fibroblastlike synoviocytes. Mol Med Rep. 17:3312–3317. 2018.PubMed/NCBI
25	Feng ZY, He ZN, Zhang B and Chen Z: Osteoprotegerin promotes the proliferation of chondrocytes and affects the expression of ADAMTS-5 and TIMP-4 through MEK/ERK signaling. Mol Med Rep. 8:1669–1679. 2013. View Article : Google Scholar : PubMed/NCBI
26	Livak KJ and Schmittgen TD: Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001. View Article : Google Scholar : PubMed/NCBI
27	Dutta P, Sarkissyan M, Paico K, Wu Y and Vadgama JV: MCP-1 is overexpressed in triple-negative breast cancers and drives cancer invasiveness and metastasis. Breast Cancer Res Treat. 170:477–486. 2018. View Article : Google Scholar : PubMed/NCBI
28	Lu E, Su J, Zhou Y, Zhang C and Wang Y: CCL20/CCR6 promotes cell proliferation and metastasis in laryngeal cancer by activating p38 pathway. Biomed Pharmacother. 85:486–492. 2017. View Article : Google Scholar : PubMed/NCBI
29	Goldbergova MP, Lipkova J, Pavek N, Pavek N, Gatterova J, Vasku A, Soucek M and Nemec P: RANTES, MCP-1 chemokines and factors describing rheumatoid arthritis. Mol Immunol. 52:273–278. 2012. View Article : Google Scholar : PubMed/NCBI
30	Scian R, Barrionuevo P, Giambartolomei GH, De Simone EA, Vanzulli SI, Fossati CA, Baldi PC and Delpino MV: Potential role of fibroblast-like synoviocytes in joint damage induced by Brucella abortus infection through production and induction of matrix metalloproteinases. Infecti Immun. 79:3619–3632. 2011. View Article : Google Scholar
31	Andreassen SM, Berg LC, Nielsen SS, Kristensen AT and Jacobsen S: mRNA expression of genes involved in inflammation and haemostasis in equine fibroblast-like synoviocytes following exposure to lipopolysaccharide, fibrinogen and thrombin. BMC Vet Res. 11:1412015. View Article : Google Scholar : PubMed/NCBI
32	Zhang L, Yu M, Deng J, Lv X, Liu J, Xiao Y, Yang W, Zhang Y and Li C: Chemokine signaling pathway involved in CCL2 expression in patients with rheumatoid arthritis. Yonsei Med J. 56:1134–1142. 2015. View Article : Google Scholar : PubMed/NCBI
33	Cho ML, Yoon BY, Ju JH, Jung YO, Jhun JY, Park MK, Park SH, Cho CS and Kim HY: Expression of CCR2A, an isoform of MCP-1 receptor, is increased by MCP-1, CD40 ligand and TGF-beta in fibroblast like synoviocytes of patients with RA. Exp Mol Med. 39:499–507. 2007. View Article : Google Scholar : PubMed/NCBI
34	Paleolog EM: Angiogenesis in rheumatoid arthritis. Arthritis Res. 4 (Suppl 3):S81–S90. 2002. View Article : Google Scholar : PubMed/NCBI
35	Hamilton JL, Nagao M, Levine BR, Chen D, Olsen BR and Im HJ: Targeting VEGF and its receptors for the treatment of osteoarthritis and associated pain. J Bone Miner Res. 31:911–924. 2016. View Article : Google Scholar : PubMed/NCBI
36	Choe JY, Lee SJ, Park SH and Kim SK: Tacrolimus (FK506) inhibits interleukin-1β-induced angiopoietin-1, Tie-2 receptor, and vascular endothelial growth factor through down-regulation of JNK and p38 pathway in human rheumatoid fibroblast-like synoviocytes. Joint Bone Spine. 79:137–143. 2012. View Article : Google Scholar : PubMed/NCBI
37	Osta B, Roux JP, Lavocat F, Pierre M, Ndongo-Thiam N, Boivin G and Miossec P: Differential effects of IL-17A and TNF-α on osteoblastic differentiation of isolated synoviocytes and on bone explants from arthritis patients. Front Immunol. 6:1512015. View Article : Google Scholar : PubMed/NCBI
38	Hms W, Toyota K, Kim S, Fang J, Bwalya EC, Hosoya K and Okumura M: Differentiation potential of synoviocytes derived from joints with cranial cruciate ligament rupture and medial patella luxation in dogs. Res Vet Sci. 114:370–377. 2017. View Article : Google Scholar : PubMed/NCBI
39	Biswas SK and Sodhi A: Effect of monocyte chemoattractant protein-1 on murine bone marrow cells: Proliferation, colony-forming ability and signal transduction pathway involved. Int J Immunopathol Pharmacol. 15:183–194. 2002. View Article : Google Scholar : PubMed/NCBI
40	Fougerat A, Smirnova NF, Gayral S, Malet N, Hirsch E, Wymann MP, Perret B, Martinez LO, Douillon M and Laffargue M: Key role of PI3Kγ in monocyte chemotactic protein-1-mediated amplification of PDGF-induced aortic smooth muscle cell migration. Br J Pharmacol. 166:1643–1653. 2012. View Article : Google Scholar : PubMed/NCBI
41	Ming Z, Yawei L, Mingmin B, Yutaka K, Jiahuai H and Eaton JW: Vascular smooth muscle cell proliferation requires both p38 and BMK1 MAP kinases. Arch Biochem Biophys. 400:199–207. 2002. View Article : Google Scholar : PubMed/NCBI
42	Liu S, Gao F, Wen L, Ouyang M, Wang Y, Wang Q, Luo L and Jian Z: Osteocalcin induces proliferation via positive activation of the PI3K/Akt, P38 MAPK pathways and promotes differentiation through activation of the GPRC6A-ERK1/2 pathway in C2C12 myoblast cells. Cell Physiol Biochem. 43:1100–1112. 2017. View Article : Google Scholar : PubMed/NCBI
43	Huang BP, Lin CH, Chen HM, Lin JT, Cheng YF and Kao SH: AMPK activation inhibits expression of proinflammatory mediators through downregulation of PI3K/p38 MAPK and NF-κB signaling in murine macrophages. DNA Cell Biol. 34:133–141. 2015. View Article : Google Scholar : PubMed/NCBI